Tung Bui

745 total citations
12 papers, 470 citations indexed

About

Tung Bui is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Tung Bui has authored 12 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Genetics. Recurrent topics in Tung Bui's work include Cancer Cells and Metastasis (4 papers), HER2/EGFR in Cancer Research (3 papers) and Immune cells in cancer (2 papers). Tung Bui is often cited by papers focused on Cancer Cells and Metastasis (4 papers), HER2/EGFR in Cancer Research (3 papers) and Immune cells in cancer (2 papers). Tung Bui collaborates with scholars based in Canada, United States and Australia. Tung Bui's co-authors include William J. Muller, Sherif Samer Attalla, Tarek Taifour, Virginie Sanguin‐Gendreau, Vincent Giguère, Morag Park, Babette Schade, Dongmei Zuo, Geneviève Deblois and Elena López‐Knowles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Immunity.

In The Last Decade

Tung Bui

12 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tung Bui Canada	10	273	195	115	87	38	12	470
Suzana Gomes United States	8	326 1.2×	103 0.5×	72 0.6×	103 1.2×	31 0.8×	14	448
Kevin O’Hayer United States	10	315 1.2×	263 1.3×	113 1.0×	88 1.0×	75 2.0×	18	568
Rashid Gabbasov United States	10	286 1.0×	158 0.8×	91 0.8×	60 0.7×	56 1.5×	21	525
Yukihiro Shiraki Japan	11	165 0.6×	135 0.7×	63 0.5×	79 0.9×	28 0.7×	29	354
Marie‐Aude Le Bitoux Switzerland	5	384 1.4×	165 0.8×	114 1.0×	159 1.8×	29 0.8×	8	592
Maria A. Voronkova United States	9	280 1.0×	119 0.6×	91 0.8×	114 1.3×	30 0.8×	15	452
Yong‐Jian Deng China	12	237 0.9×	153 0.8×	68 0.6×	108 1.2×	53 1.4×	21	424
Katie E. Hebron United States	8	164 0.6×	97 0.5×	118 1.0×	48 0.6×	44 1.2×	12	348
Elizabeth A. Loughran United States	7	202 0.7×	132 0.7×	53 0.5×	90 1.0×	61 1.6×	9	393
Hsin‐Yi Lan Taiwan	5	236 0.9×	219 1.1×	90 0.8×	167 1.9×	39 1.0×	6	463

Countries citing papers authored by Tung Bui

Since Specialization

Citations

This map shows the geographic impact of Tung Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tung Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tung Bui more than expected).

Fields of papers citing papers by Tung Bui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tung Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tung Bui. The network helps show where Tung Bui may publish in the future.

Co-authorship network of co-authors of Tung Bui

This figure shows the co-authorship network connecting the top 25 collaborators of Tung Bui. A scholar is included among the top collaborators of Tung Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tung Bui. Tung Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Taifour, Tarek, Tung Bui, Dongmei Zuo, et al.. (2024). Osteopontin is a therapeutic target that drives breast cancer recurrence. Nature Communications. 15(1). 9174–9174. 17 indexed citations

Taifour, Tarek, Sherif Samer Attalla, Dongmei Zuo, et al.. (2024). Abstract PO2-25-01: Tumor Derived Chitinase-3 like 1 Induces Neutrophil Extracellular Traps that Promote T cell Exclusion and Resistance to Immunotherapies in Breast Cancer. Cancer Research. 84(9_Supplement). PO2–25. 1 indexed citations

Taifour, Tarek, Sherif Samer Attalla, Dongmei Zuo, et al.. (2023). The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity. 56(12). 2755–2772.e8. 70 indexed citations

Bui, Tung, Dongmei Zuo, Virginie Sanguin‐Gendreau, et al.. (2022). Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer. Oncogene. 41(25). 3445–3451. 3 indexed citations

Bui, Tung, et al.. (2022). Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer. Endocrinology. 163(6). 14 indexed citations

Bui, Tung, et al.. (2021). Emergence of β1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment. Oncogene. 41(4). 527–537. 19 indexed citations

Attalla, Sherif Samer, Tarek Taifour, Tung Bui, & William J. Muller. (2020). Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo. Oncogene. 40(3). 475–491. 125 indexed citations

Bui, Tung, Jonathan Rennhack, Ling Chen, et al.. (2019). Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer. Cell Reports. 29(3). 589–602.e6. 34 indexed citations

Smith, Harvey W., Dongmei Zuo, Catherine R. Dufour, et al.. (2018). Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program. Nature Communications. 9(1). 2547–2547. 64 indexed citations

10.

Bui, Tung, Babette Schade, Robert D. Cardiff, et al.. (2017). β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model. Proceedings of the National Academy of Sciences. 114(5). E707–E716. 22 indexed citations

11.

Schade, Babette, Robert Lesurf, Virginie Sanguin‐Gendreau, et al.. (2013). β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression. Cancer Research. 73(14). 4474–4487. 71 indexed citations

12.

Nadeem, Lubna, et al.. (2012). Cytoplasmic mislocalization of p27 and CDK2 mediates the anti-migratory and anti-proliferative effects of Nodal in human trophoblast cells. Journal of Cell Science. 126(2). 445–453. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact